Risankizumab as an effective therapeutic option in severe psoriasis unsuccessfully treated with therapies involving anti- TNF-α and anti-IL-17 - Adamczyk, Michał; Krasowska, Dorota (Dermatology Review/Przegląd Dermatologiczny, 2020)